REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 182 filers reported holding REGENXBIO INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,648 | -17.7% | 16,382 | 0.0% | 0.00% | – |
| Q2 2023 | $327,476 | +10.3% | 16,382 | +4.3% | 0.00% | – |
| Q1 2023 | $296,906 | -54.4% | 15,701 | -45.2% | 0.00% | – |
| Q4 2022 | $651,366 | -27.0% | 28,643 | -17.8% | 0.00% | -100.0% |
| Q3 2022 | $892,591 | +4.5% | 34,843 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $853,781 | -19.9% | 34,900 | +8.4% | 0.00% | 0.0% |
| Q1 2022 | $1,065,940 | +60.1% | 32,183 | +57.4% | 0.00% | – |
| Q4 2021 | $666,000 | -23.6% | 20,443 | -1.7% | 0.00% | -100.0% |
| Q3 2021 | $872,000 | -0.2% | 20,796 | -7.5% | 0.00% | 0.0% |
| Q2 2021 | $874,000 | +15.8% | 22,492 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $755,000 | -19.6% | 22,131 | +6.9% | 0.00% | 0.0% |
| Q4 2020 | $939,000 | +70.1% | 20,695 | +3.2% | 0.00% | 0.0% |
| Q3 2020 | $552,000 | -26.8% | 20,053 | -1.7% | 0.00% | 0.0% |
| Q2 2020 | $754,000 | +9.1% | 20,401 | -4.4% | 0.00% | 0.0% |
| Q1 2020 | $691,000 | -16.4% | 21,334 | +5.7% | 0.00% | 0.0% |
| Q4 2019 | $827,000 | +19.5% | 20,175 | -2.8% | 0.00% | 0.0% |
| Q3 2019 | $692,000 | -35.1% | 20,755 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $1,067,000 | -11.2% | 20,773 | -0.9% | 0.00% | 0.0% |
| Q1 2019 | $1,202,000 | +46.2% | 20,971 | +7.0% | 0.00% | 0.0% |
| Q4 2018 | $822,000 | -46.9% | 19,604 | -4.4% | 0.00% | -50.0% |
| Q3 2018 | $1,548,000 | +1.8% | 20,496 | -3.3% | 0.00% | 0.0% |
| Q2 2018 | $1,521,000 | +142.6% | 21,199 | +1.0% | 0.00% | +100.0% |
| Q1 2018 | $627,000 | -10.8% | 20,989 | -0.9% | 0.00% | 0.0% |
| Q4 2017 | $703,000 | +1.6% | 21,172 | +0.8% | 0.00% | 0.0% |
| Q3 2017 | $692,000 | +60.6% | 21,000 | -3.7% | 0.00% | 0.0% |
| Q2 2017 | $431,000 | +37.7% | 21,817 | +34.8% | 0.00% | – |
| Q1 2017 | $313,000 | +20.8% | 16,190 | +15.9% | 0.00% | – |
| Q4 2016 | $259,000 | +22.7% | 13,967 | -7.0% | 0.00% | – |
| Q3 2016 | $211,000 | +73.0% | 15,016 | -2.0% | 0.00% | – |
| Q2 2016 | $122,000 | +238.9% | 15,318 | +326.8% | 0.00% | – |
| Q1 2016 | $36,000 | – | 3,589 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |